Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A ordinary shares, par value $0.0001 per share
-
Shares outstanding
-
19,597,244
-
Total 13F shares
-
16,680,578
-
Share change
-
+199,049
-
Total reported value
-
$175,078,843
-
Price per share
-
$10.51
-
Number of holders
-
48
-
Value change
-
+$2,165,221
-
Number of buys
-
15
-
Number of sells
-
13
Institutional Holders of Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACC) as of Q3 2025
As of 30 Sep 2025,
Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACC) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,680,578 shares.
The largest 10 holders included
AQR Arbitrage LLC, TORONTO DOMINION BANK, D. E. Shaw & Co., Inc., Empyrean Capital Partners, LP, Boussard & Gavaudan Investment Management LLP, Driehaus Capital Management LLC, HighTower Advisors, LLC, Decagon Asset Management LLP, Linden Advisors LP, and GOLDMAN SACHS GROUP INC.
This page lists
48
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.